Sandra Gavart Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

1/2020

A Real-World Analysis of Patient Characteristics and Predictors of Hospitalization Among US Medicare Beneficiaries with Respiratory Syncytial Virus Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Gavart Research Topics

Disease

2	Chronic Hepatitis C 01/2014 - 01/2014
2	Infections 01/2014 - 01/2014
2	Disease Progression 01/2014 - 01/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Fibrosis (Cirrhosis) 01/2014

Drug/Important Bio-Agent (IBA)

2	Ribavirin (Virazole)FDA LinkGeneric 01/2014 - 01/2014
2	Interferon-alpha (Interferon Alfa)IBA 01/2014 - 01/2014
2	telaprevirIBA 01/2014 - 01/2014
2	Antiviral Agents (Antivirals)IBA 01/2014 - 01/2014
1	CholesterolIBA 01/2020
1	InterleukinsIBA 01/2014
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2014

Therapy/Procedure

2	Therapeutics 01/2014 - 01/2014